TITLE

A REVIEW OF RECENT FEDERAL LEGISLATIVE AND POLICY INITIATIVES TO ENHANCE THE DEVELOPMENT AND EVALUATION OF HIGH VALUE DRUGS IN THE UNITED STATES

AUTHOR(S)
Neyarapally, George A.
PUB. DATE
March 2013
SOURCE
DePaul Journal of Health Care Law;Spring2013, Vol. 14 Issue 3, p503
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on federal legislative and government policy initiatives for the developments and evaluation of high value drugs in the U.S. Topics include legislative initiatives under the U.S. Food and Drug Administration's (FDA) Safety and Innovation Act, American Recovery and Reinvestment Act (ARRA) funding for federal comparative effectiveness research, and Patient Protection and Affordable Care Act (PPACA) for medication therapy Management.
ACCESSION #
93380582

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics